20. November 2009 08:37
Ligand Pharmaceuticals Incorporated today announced that data from a preclinical study on its selective androgen receptor modulator (SARM) LGD-4033 was featured in a poster presentation at the 62nd Annual Meeting of the Gerontology Society of America in Atlanta. LGD-4033 exhibited desirable in vivo efficacy on skeletal muscle and bone measurements in animal models of male hypogonadism and postmenopausal osteoporosis.
[More]
f23b18ab-0bd0-4d21-ad99-95fb9aaafa02|0|.0
Posted in: Medical Science News | Medical Condition News
Tags: Anemia, Arthritis, Asthma, Biotechnology, Bone, Bone Mineral Density, Cancer, Cell, Gene Expression, Gerontology, Osteoporosis, Pfizer, Psoriasis, Rheumatoid Arthritis, Sexual Dysfunction, Testosterone
19. November 2009 22:41
Ligand Pharmaceuticals Incorporated announced today that it has received $2 million in milestone payments from N. V. Organon, a subsidiary of Merck & Co., Inc., stemming from its research collaboration that is due to expire at the end of December.
[More]
19. November 2009 03:13
Genentech, Inc., a wholly-owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), and Biogen Idec announced today that the U.S. Food and Drug Administration (FDA) issued a complete response on the companies’ applications for Rituxan® (rituximab) plus fludarabine and cyclophosphamide (FC) for the treatment of people with previously untreated and previously treated chronic lymphocytic leukemia (CLL).
[More]
7169822c-90e7-4db1-bb27-26e0162bbe54|0|.0
Posted in: Medical Condition News | Pharmaceutical News
Tags: Anthracycline, Antibody, Arthritis, Biotechnology, Bone, Bone Marrow, Brain, Cancer, Cell, Chemotherapy, Chronic Lymphocytic Leukemia, Cough, Cyclophosphamide, Headache, Hepatitis B, Leukemia, Lymphoma, MabThera, Methotrexate, Multiple Sclerosis, Nausea, Rheumatoid Arthritis, Rituximab, Virus
19. November 2009 00:49
Viron Therapeutics Inc., a biotechnology company pioneering the development of immune-modulating protein therapeutics derived from pathogens, today reported results from a Phase IIa clinical trial evaluating VT-111 (Serp-1), an anti-inflammatory protein derived from the myxoma virus.
[More]
259b6317-e2c9-41a9-839b-c824711a233a|0|.0
Posted in: Drug Trial News | Pharmaceutical News
Tags: Anti-Inflammatory, Arthritis, Biomarker, Biotechnology, Cardiovascular Disease, Hospital, Macrophage, Rheumatoid Arthritis, Stent, Transplant, Ultrasound, Virus
18. November 2009 07:41
Arrayit Corporation announced today that the new High Throughput Biology Center at Johns Hopkins University School of Medicine in Baltimore Maryland purchased Arrayit's proprietary technology to create a Human Proteome Chip to discover biomarkers for autoimmune diseases including rheumatoid arthritis, inflammatory bowel disease, autoimmune hepatitis (first identified by Dr. Zhu), lupus, and others.
[More]
18. November 2009 02:09
Researchers at the La Jolla Institute for Allergy & Immunology have found that previous influenza infections may provide at least some level of immunity to the H1N1 "swine" flu. "The question we asked was, "Is the swine flu more like the seasonal flu or like a totally new strain of influenza where there would be no immunity?," said Alessandro Sette, Ph.D., an internationally recognized vaccine expert and director of the La Jolla Institute's Center for Infectious Disease.
[More]
09d5d26a-5949-4652-b94d-3313d33b6c2e|0|.0
Posted in: Disease/Infection News
Tags: Allergy, Antibody, Arthritis, Asthma, Cancer, CDC, Cell, Crohn's Disease, Diabetes, H1N1, Immunology, Influenza, Rheumatoid Arthritis, Swine Flu, Vaccine, Virus
17. November 2009 03:22
Galapagos NV announced today that it has started a Phase II clinical study to evaluate Nanocort's effectiveness in treating flares in multiple sclerosis (MS). Nanocort combines less frequent treatment with lower dosage and potentially more effective delivery than other MS flare treatments.
[More]
c671443c-7394-49e8-a18e-5988be78afd0|0|.0
Posted in: Drug Trial News
Tags: Antibody, Arthritis, Autoimmune Disease, Bone, Brain, Corticosteroid, Liposome, Metastasis, Multiple Sclerosis, Myelin, Nervous System, Rheumatoid Arthritis, Steroid
17. November 2009 01:53
Cold weather triggers a painful and sometimes debilitating disorder for millions of Americans who suffer from Raynaud's disease (also known as Raynaud's syndrome or phenomenon). Raynaud's is an autoimmune disorder in which spasms in the blood vessels can interrupt blood flow to the fingers, toes, nose and ears. Exposure to cold triggers the spasms, typically causing the affected area to turn white, then blue, then bright red. Emotional stress can also cause an attack.
[More]
16. November 2009 10:19
4SC AG, a drug discovery and development company, today announced the successful completion of a capital increase, after the Management Board, with the approval of the Supervisory Board, passed a resolution to authorise an increase of share capital on 23 October, 2009.
[More]
16. November 2009 07:37
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today reported results for the three- and nine-month periods ending September 30, 2009.
[More]
16. November 2009 06:42
Inovio Biomedical Corporation today reported financial results for the three and nine months ended September 30, 2009.
[More]
fd796e5e-208d-417d-9b00-0ff666bb589e|0|.0
Posted in: Business / Finance | Pharmaceutical News
Tags: Allergy, Antibody, Anti-Inflammatory, Antiviral Drug, Arthritis, Avian Influenza, Cancer, Cell, Cervical Cancer, Diabetes, DNA, Exercise, Gene Expression, Gene Therapy, H1N1, H5N1, Hepatitis C, Influenza, Investment, Malaria, New Drug Application, Pandemic, Prostate Cancer, Rheumatoid Arthritis, Swine Flu, Vaccine, Virus
13. November 2009 01:18
Lexicon Pharmaceuticals, Inc. announced today that the company's investigational new drug, LX1031, a tryptophan hydroxylase (TPH) inhibitor, demonstrated positive results in clinically important parameters for the treatment of non-constipating irritable bowel syndrome (IBS).
[More]
b8bfc27c-e4f7-4931-bfab-38e1c3d4316b|0|.0
Posted in: Drug Trial News | Medical Condition News
Tags: Abdominal Pain, Arthritis, Autoimmune Disease, Biomarker, Constipation, Diabetes, Diarrhea, Glaucoma, Irritable Bowel Syndrome, Rheumatoid Arthritis, Serotonin, Tryptophan, Type 2 Diabetes
12. November 2009 09:29
Pharmos Corporation today reported financial results for the third quarter and nine-month period ended September 30, 2009.
[More]
12. November 2009 08:51
arGentis Pharmaceuticals, LLC today announced that it will collaborate with the University of Tennessee Health Science Center (UTHSC) and the Veterans Affairs Medical Center of Memphis (VAMC) to initiate the first human clinical evaluation of an oral altered peptide ligand (APL), ARG301, in a Phase I study of Rheumatoid Arthritis patients.
[More]
12. November 2009 03:07
Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced a new licensing agreement for Oxoferin(TM), its topical wound healing agent, and additional details of the funding assistance to be provided by the Development Bank of Saxony for the development of WF10.
[More]
922ef69d-cb26-41b9-aac6-199d5dca9bc3|0|.0
Posted in: Business / Finance | Pharmaceutical News
Tags: Anti-Inflammatory, Arthritis, Atherosclerosis, Cancer, Cell, Diabetes, Drug Delivery, Immunology, Macrophage, Rheumatoid Arthritis, Rhinitis, Wound Healing
Subscribe